PET/CT in anal cancer — is it worth doing?
Authors:
- I.T. WellsIWI.T. Wells
- B.M. FoxBFB.M. Fox
- 1 June 2012
- journal article
- Published by Elsevier in Clinical Radiology
- Vol. 67 (6) , 535-540
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Contrast-Enhanced [18F]fluorodeoxyglucose-Positron Emission Tomography/Computed Tomography for Staging and Radiotherapy Planning in Patients With Anal CancerInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2011
- Impact of FDG PET/CT in the staging and the follow-up of anal carcinomaInternational Journal of Colorectal Disease, 2010
- Anal cancer maximum F-18 fluorodeoxyglucose uptake on positron emission tomography is correlated with prognosisRadiotherapy and Oncology, 2010
- Comparison of Positron Emission Tomography Scanning and Sentinel Node Biopsy in the Detection of Inguinal Node Metastases in Patients With Anal CancerInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2010
- The impact of 18-fluorodeoxyglucose positron emission tomography on the staging, management and outcome of anal cancerBritish Journal of Cancer, 2009
- Assessing the impact of FDG-PET in the management of anal cancerRadiotherapy and Oncology, 2008
- FDG-PET/CT in the evaluation of anal carcinomaInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2006
- Positron Emission Tomography for Pretreatment Staging and Posttreatment Evaluation in Cancer of the Anal CanalMolecular Imaging and Biology, 2005
- Anal cancer incidence and survival: The Surveillance, Epidemiology, and End Results experience, 1973–2000Cancer, 2004
- CT of malignant anal canal tumors.RadioGraphics, 1990